Abstract:Objective: To develop a Gd-based MR probe containing arginine-glycine-aspartic acid (RGD) motif to reveal integrin αvβ3 receptor-expressed tumor. Methods: Commercially available HYNIC-RGD conjugate with co-ligand EDDA was labeled with GdCl 3, and the mixture was isolated and purified by solid phase extract (SPE) to get the entire probe Gd-EDDA-HYNIC-RGD. Human HCC cell line BEL-7402 was cultured and the cells harvested and suspended then subcutaneously inoculated into athymic nude mice for tumor growth. In vitro cell binding assay to integrin αvβ3 receptor and cell viability experiments were conducted. Then in vivo, imaging of the three arms of xenografts were performed by MR scan with a dedicated animal coil at baseline and time points of 0, 30, 60, 90 minutes and 24 hour post-intravenous injection (p. i.) via the tail vein. Three arms of nude mice then were sacrificed for histological examination to confirm the imaging results. Results: Gd-EDDA-HYNIC-RGD was successfully isolated by SPE and validity was verified on signal enhancement through in vitro and in vivo experiments. The T 1 relaxation rate of the probe is 3.31 mmol/s; It is well tolerated to living cells when the concentration of the probe is below 0.1 μmol/ml;both BEL-7402 Human Hepatocellular Carcinoma cell line and the tumor expressed αvβ3 receptor; The RGD-ligand was observed specificly binding with αβ3 receptor in vitro; The nude mice model bearing HHCC was well established. The signal intensity (SI) at the tumor site were 2247.6 ± 39.0 at baseline and 2820.9 ± 35.2 at 90 min p. i. respectively, the SI at 90min increased less than 25% of baseline, which is statistically different (t = - 38.031, P <0.05); while the SI at muscle site were 1824.2 ± 32.8 and 1845.8 ± 27.2 respectively, which is not statistically different (t = - 1.424, P >0.05); The signal to time curve for probe-administrated group is straightforward over time in the span of 0 to 90 minute p. i. while the control arms do not show such tendency. Conclusion: Gd-EDDA-HYNIC-RGD has the potential to used as an MR probe detecting integrin αβ3 receptor-expressed tumor. This work may offer possibility of early detection and differentiation of specific tumors.

MR Imaging of Activated Hepatic Stellate Cells in Liver Injured by CCl 4 of Rats with Integrin-Targeted Ultrasmall Superparamagnetic Iron Oxide

Molecular Magnetic Resonance Imaging of Activated Hepatic Stellate Cells with Ultrasmall Superparamagnetic Iron Oxide Targeting Integrin αvβ3 for Staging Liver Fibrosis in Rat Model

Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model

Molecular Imaging of Hepatic Stellate Cell Activity by Visualization of Hepatic Integrin Αvβ3 Expression with SPECT in Rat

Enhanced US/CT/MR imaging of integrin αvβ3 for liver fibrosis staging in rat

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

Construction of cRGD-iron oxide nanoparticles and its application in the tumor diagnosis by magnetic resonance imaging

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats

Integrin-Targeted Theranostic Nanoparticles for Clinical MRI-Traceable Treatment of Liver Fibrosis

Integrin receptor targeted cRGD-conjugated magnetic nanoparticles forvitro imaging experimental hepatic cancer cells

The Experimental Study on Tropism of Magnetic Labeled Bone Marrow Mesenchymal Stem Cells for Hepatocellular Carcinoma

Preparation of MR Molecular Probe Targeting Integrin Αvβ3 Receptor and Its in Vitro Imaging

Specific Targeting of Angiogenesis in Lung Cancer with RGD-conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a 4.7T Magnetic Resonance Scanner.

T 1-T2 Dual-Modal Magnetic Resonance Contrast-Enhanced Imaging for Rat Liver Fibrosis Stage

Targeting Activated Hepatic Stellate Cells (ahscs) for Liver Fibrosis Imaging

In Vitro and in Vivo Magnetic Resonance Imaging with Chlorotoxin-Conjugated Superparamagnetic Nanoprobes for Targeting Hepatocarcinoma.

Preliminary study of molecular imaging of human hepatocellular carcinoma xenograft with Gd-based MR probe containing arginine-glycine-aspartic acid chelate

Using PEGylated Iron Oxide Nanoparticles with Ultrahigh Relaxivity for MR Imaging of an Orthotopic Model of Human Hepatocellular Carcinoma

Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.